Voyager Therapeutics Email Formats

Biotechnology Research • 75 Hayden Ave, Lexington, United States • 101-200 Employees

Voyager Therapeutics Email Formats

Voyager Therapeutics uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 51.3% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	51.3%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	21.8%
{first name}@company.com	john@company.com	11.2%
{last name}.{first name}@company.com	doe.john@company.com	9.1%
{first name}_{last name}@company.com	john_doe@company.com	6.6%

Overview About Employees Insights Funding Tech Stack Trending Companies FAQ

Company overview

Headquarters	75 Hayden Ave, Lexington, Massachusetts 02421, US
Phone number	+18572595340
Website	voyagertherapeutics.com
NAICS	541714
SIC	873
Keywords	Biotechnology, Gene Therapy, Research, ALS, Neurology, CNS, Tauopathies, Adeno Associated Virus, Parkinson'S Disease, Amyotrophic Lateral Sclerosis, Alzheimer'S Disease, Gene Therapy, Neuropharmacology, Huntington'S Disease, Friedrich'S Ataxia, SF9, Vector Engineering
Founded	2014
Employees	101-200
Socials

About Voyager Therapeutics

Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, Friedreich’s ataxia, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACER™ AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs are wholly owned, and some are advancing with partners including Alexion, AstraZeneca Rare Disease; Novartis Pharma AG; and Neurocrine Biosciences, Inc. For more information, visit www.voyagertherapeutics.com. Voyager Therapeutics® is a registered trademark, and TRACER™ is a trademark, of Voyager Therapeutics, Inc.

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Senior

Entry

Director

Employees by Department

Voyager Therapeutics has 92 employees across 12 departments.

Departments

Number of employees

Funding Data

Explore Voyager Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-02-09	14	$39,000,000
2024-02-04	14	$100,000,000

Funding Insights

$139,000,000

Total funding amount

$100,000,000

Most recent funding amount

Number of funding rounds

Voyager Therapeutics Tech Stack

Discover the technologies and tools that power Voyager Therapeutics's digital infrastructure, from frameworks to analytics platforms.

MediaElement.js

Video players

reCAPTCHA

Security

jQuery Mobile

Mobile frameworks

jQuery Migrate

JavaScript libraries

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

PHP

Programming languages

WordPress

Blogs

Divi

Page builders

Google Analytics

Analytics

Google Tag Manager

Tag managers

Nginx

Reverse proxies

Frequently asked questions

Voyager Therapeutics is located in 75 Hayden Ave, Lexington, US.

You can reach Voyager Therapeutics at +18572595340.

Voyager Therapeutics was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

Voyager Therapeutics has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

Voyager Therapeutics has raised a total of $139,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Voyager Therapeutics

Al Sandrock

Chief Executive Officer

4.8

40,000 users